Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carcass Quality Profiles and Associated Genomic Regions of South African Goat Populations Investigated Using Goat SNP50K Genotypes. | Animals (Basel) | 2022 | 35158687 | PubTator, text mining | PubMed |
| Exosomes in Pathogenesis, Diagnosis, and Treatment of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35155236 | PubTator, text mining | PubMed |
| The correlation and role analysis of SLC30A1 and SLC30A10 in cervical carcinoma. | J Cancer | 2022 | 35154468 | PubTator, text mining | PubMed |
| Identification of a Four-Gene Signature for Determining the Prognosis of Papillary Thyroid Carcinoma by Integrated Bioinformatics Analysis. | Int J Gen Med | 2022 | 35153506 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. | J Immunother Cancer | 2022 | 35140113 | PubTator, text mining | PubMed |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. | NPJ Syst Biol Appl | 2022 | 35132075 | PubTator, text mining | PubMed |
| Recurrent pneumothorax in a case of tenascin-X deficient Ehlers-Danlos syndrome: Broadening the phenotypic spectrum. | Am J Med Genet A | 2022 | 35128805 | PubTator, text mining | PubMed |
| Construction and comprehensive analysis of the competing endogenous RNA network in endometrial adenocarcinoma. | BMC Genom Data | 2022 | 35123404 | PubTator, text mining | PubMed |
| DNA methylation changes in glial cells of the normal-appearing white matter in Multiple Sclerosis patients. | Epigenetics | 2022 | 35094644 | PubTator, text mining | PubMed |
| Trophectoderm differentiation to invasive syncytiotrophoblast is promoted by endometrial epithelial cells during human embryo implantation. | Hum Reprod | 2022 | 35079788 | PubTator, text mining | PubMed |
| Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression. | PeerJ | 2022 | 35070500 | PubTator, text mining | PubMed |
| Retraction: MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. | PLoS One | 2022 | 35061812 | PubTator, text mining | PubMed |
| Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant's Superior Transmission. | Int J Mol Sci | 2022 | 35054983 | PubTator, text mining | PubMed |
| A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC. | Cancers (Basel) | 2022 | 35053601 | PubTator, text mining | PubMed |
| The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function. | Cell Mol Life Sci | 2022 | 35044529 | PubTator, text mining | PubMed |
| The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review. | Clin Exp Ophthalmol | 2022 | 35037362 | PubTator, text mining | PubMed |
| Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. | Mol Cancer | 2022 | 35031075 | PubTator, text mining | PubMed |
| Phenotypic, trophic, and regenerative properties of mesenchymal stem cells from different osseous tissues. | Cell Tissue Res | 2022 | 35028747 | PubTator, text mining | PubMed |
| Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. | Cell Rep | 2022 | 35026155 | PubTator, text mining | PubMed |
| Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients. | Aging Cell | 2022 | 35023286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=34